Amgen Inc. buy Royal Bank of Canada
Start price
03.04.24
/
50%
€254.85
Target price
03.04.25
€304.82
Performance (%)
17.94%
Price
28.08.24
€296.45
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 17.94%. Dividends of €4.11 are taken into consideration when calculating the performance. This prediction currently runs until 03.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.406% | 0.406% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat